搜索临床试验以:TF2 (Recombinant, humanized Tri-Fab bsMAb composed of 2 humanized MN-14 anti-CEA Fab x and one 679 a
总计495532个结果
-
Sinovac Research and Development Co., Ltd.完全的
-
Gazi UniversityHacettepe University; Cukurova University; Marmara University; Istanbul University; TC Erciyes University 和其他合作者未知
-
Memorial Sloan Kettering Cancer CenterUniversity of Pittsburgh; Ohio State University招聘中
-
Haihe Biopharma Co., Ltd.招聘中
-
Memorial Sloan Kettering Cancer CenterBristol-Myers Squibb完全的
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Dana-Farber Cancer Institute; University of Pittsburgh完全的
-
Sanofi Pasteur, a Sanofi Company完全的
-
Novartis Pharmaceuticals完全的急性髓性白血病 | 难治性白血病比利时, 大韩民国, 火鸡, 德国, 澳大利亚, 法国, 瑞士, 英国, 西班牙, 意大利, 秘鲁, 美国
-
Chugai PharmaceuticalJapan Lung Cancer Society完全的
-
Dana-Farber Cancer InstitutePrometheus Laboratories主动,不招人
-
Memorial Sloan Kettering Cancer CenterNovartis完全的淋巴瘤 | 原发性中枢神经系统淋巴瘤 | 复发/难治性继发性中枢神经系统淋巴瘤美国
-
Michigan State UniversityConsumer Healthcare Products Association完全的
-
PATHSyneos Health; Research Institute for Tropical Medicine; DF/Net Research, Inc.完全的
-
Glostrup University Hospital, CopenhagenSteno Diabetes Centre, Gentofte, Denmark完全的心血管疾病 | 哮喘 | 过敏 | 2型糖尿病 | 骨质疏松症
-
VA Office of Research and Development招聘中
-
Univ.-Doz. Dr.med.univ. Gernot Hudelist, MSc.招聘中